Gemcitabine Plus Docetaxel, Dacarbazine, Doxorubicin Combinations, or Doxorubicin Alone as First-Line Treatment for Advanced/Metastatic Leiomyosarcoma: A Retrospective Analysis at a Sarcoma Center

Background/Objectives: Locally advanced and metastatic leiomyosarcoma (LMS) is an aggressive cancer with limited treatment options. This single-institution, retrospective study evaluated the efficacy of first-line chemotherapy regimens in patients with advanced or metastatic LMS treated at Stanford...

Full description

Bibliographic Details

Published in:	Diseases
Main Authors:	Ted Kim, Clara Hao, Minggui Pan, Kristen N. Ganjoo, Nam Q. Bui
Format:	Article
Language:	English
Published:	MDPI AG 2025-03-01
Subjects:	leiomyosarcoma soft tissue sarcoma chemotherapy doxorubicin progression-free survival overall survival
Online Access:	https://www.mdpi.com/2079-9721/13/3/79